Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia.

Journal Article

Full Text

Duke Authors

Cited Authors

  • Rizzieri, DA; Long, GD; Gasparetto, C; Smith, CS; Vredenburgh, JJ; Morris, AK; Petros, WP; Loftis, J; McDonald, CS; Waters-Pick, B; Adams, DJ; Chao, NJ

Published Date

  • November 16, 2000

Published In

Volume / Issue

  • 96 / 11

Start / End Page

  • 385A - 385A

International Standard Serial Number (ISSN)

  • 0006-4971